<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Robert F Kennedy Jr | Noti Group</title>
    <link>https://noti.group/profile/robert-f-kennedy-jr/</link>
    <description>Noti Group, the international news group: world news, business, health, sports, technology, entertainment, lifestyle and investigative journalism.</description>
    <language>en</language>
    <lastBuildDate>Tue, 17 Nov 2026 17:38:55 GMT</lastBuildDate>
    <generator>Noti Group platform</generator>
    <copyright>Noti Group. CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/): free to republish with credit to Noti Group and a link to the story. Photos not included.</copyright>
    <atom:link href="https://noti.group/profile/robert-f-kennedy-jr/rss.xml" rel="self" type="application/rss+xml"/>
    <atom:link href="https://pubsubhubbub.appspot.com/" rel="hub"/>
    <item>
      <title>Measles No Longer Eliminated in US After 25 Years</title>
      <link>https://noti.group/measles-no-longer-eliminated-in-us-after-25-years/</link>
      <guid isPermaLink="true">https://noti.group/measles-no-longer-eliminated-in-us-after-25-years/</guid>
      <pubDate>Tue, 17 Nov 2026 16:53:51 GMT</pubDate>
      <dc:creator>Noti Group</dc:creator>
      <category>Business</category>
      <description><![CDATA[The Pan American Health Organization has determined that measles is now endemic in the United States due to ongoing outbreaks.]]></description>
      <content:encoded><![CDATA[<p>The United States has lost its official status as a country free from measles, a designation it had held for over 25 years. This decision was made by the Pan American Health Organization (PAHO) after reviewing the country's epidemiological evidence with a panel of eight scientific experts.</p><p>Following a thorough examination, PAHO determined that the highly contagious virus is now endemic in the US, meaning it is consistently present and spreading throughout the country. The organization based its conclusion on 12 months of continuous transmission, which has led to ongoing outbreaks.</p><p>The decision to withdraw measles elimination status was made by Dr. Jarbas Barbosa, director of PAHO, who accepted a recommendation from an independent panel of experts. This move acknowledges that measles is no longer eliminated in the US but instead spreads regularly throughout the country.</p><p>Measles outbreaks have been fuelled by declining childhood vaccination rates and growing vaccine hesitancy across America. The consequences have been severe, with thousands of people infected and a tragic loss of life resulting from preventable deaths.</p><p>The World Health Organization's partner in the Americas, PAHO, is working closely with countries to strengthen their response to measles outbreaks. This includes ramping up vaccination efforts and improving surveillance systems to quickly identify and contain cases.</p><p>Dr. Daniel Salas, executive manager of PAHO's Special Program for Comprehensive Immunization, notes that countries are taking proactive steps to control the spread of the disease. He highlights the US as an example where vaccination efforts are being intensified in areas with low immunization coverage experiencing outbreaks.</p><p>The Centers for Disease Control and Prevention (CDC) has announced its commitment to supporting states and local partners in preventing and responding to measles outbreaks. In a recent release, CDC Director Dr. Erica Schwartz emphasized that vaccination is the key to protecting Americans from measles, not the elimination designation itself.</p><p>According to the CDC, significant investments have been made in state and local health departments to reach communities where transmission is occurring. This includes $100 million allocated for outreach efforts in areas with low immunization coverage.</p><p>The loss of measles elimination status poses a challenge for the Trump administration's Health and Human Services Secretary Robert F. Kennedy Jr., who has been vocal about questioning the safety of childhood vaccines without evidence.</p><p>The Centers for Disease Control and Prevention seems unlikely to alter its approach to measles despite the country's loss of measles elimination status. This stance was reinforced by CDC Director Dr. Erica Schwartz last week, who stated that the agency would continue doing what it has been doing if the U.S. loses its measles-free designation.</p><p>According to Schwartz, this means reemphasizing that vaccination is the most effective way to prevent measles. The CDC works closely with states to contain outbreaks and relies on the MMR vaccine as the primary tool in this effort. This approach has been consistent despite growing concerns about the nation's public health system.</p><p>The return of measles in the U.S. highlights weaknesses in the country's public health infrastructure, raising fears that other eliminated diseases may make a comeback. Trust in health institutions is eroding, and persuading people to protect themselves, their families, and communities has become increasingly challenging.</p><p>Public health experts point out that the resurgence of measles can be attributed to declining vaccination rates among children. The MMR vaccine is highly effective, with two doses providing about 97% protection against measles and a single dose offering 93% protection.</p><p>Data from the CDC indicates that vaccination coverage for kindergarteners fell below the recommended threshold in the 2025-2026 school year, standing at 92.4%. This level of coverage is lower than the 95% mark public health officials generally recommend to prevent sustained measles transmission.</p><p>The economic toll of the ongoing measles outbreaks in the US is substantial, with estimated costs reaching nearly $83 million this year alone. This figure breaks down into $56 million for public health response efforts, almost $25 million for lost productivity, and over $1.8 million for direct medical expenses.</p><p>The loss of measles elimination status by the US joins several other countries, including Canada, Spain, and the UK, which have also recently been reclassified as having ongoing measles transmission. Despite this setback, the US remains a member of PAHO, its Americas branch within the World Health Organization.</p><p><em>CNBC</em>: <a href="https://www.cnbc.com/2026/11/17/us-measles-elimination-status.html">https://www.cnbc.com/2026/11/17/us-measles-elimination-status.html</a></p>]]></content:encoded>
      <enclosure url="https://noti.group/media/u-s-officially-loses-measles-elimination-status-amid-ongoing-outbreaks.webp" type="image/webp" length="0"/>
      <media:content url="https://noti.group/media/u-s-officially-loses-measles-elimination-status-amid-ongoing-outbreaks.webp" medium="image" width="1400" height="788"><media:title>Measles No Longer Eliminated in US After 25 Years</media:title></media:content>
    </item>
    <item>
      <title>Vaccine Trial Researchers&apos; Offices Raided by Police in Guinea-Bissau</title>
      <link>https://noti.group/vaccine-trial-researchers-offices-raided-by-police-in-guinea-bissau/</link>
      <guid isPermaLink="true">https://noti.group/vaccine-trial-researchers-offices-raided-by-police-in-guinea-bissau/</guid>
      <pubDate>Tue, 20 Oct 2026 19:18:03 GMT</pubDate>
      <dc:creator>Noti Group</dc:creator>
      <category>World News</category>
      <description><![CDATA[Police in Guinea-Bissau have raided offices of researchers involved in a vaccine trial, seizing doses of hepatitis B vaccines as part of an investigation.]]></description>
      <content:encoded><![CDATA[<p>Police in Guinea-Bissau raided offices of researchers at the center of an ongoing dispute over vaccine trials involving African newborns, seizing doses of hepatitis B vaccines as part of an investigation into the matter.</p><p>The researchers had received significant funding for their work, with a total of $3.2m provided by US and international organizations, including the US Centers for Disease Control and Prevention (CDC) and private foundations such as the Pershing Square Foundation and the Bluebell Foundation.</p><p>According to officials, the police search was aimed at clarifying the circumstances surrounding the seized vaccines, with no indication that the immunizations themselves were of poor quality or effectiveness. The move has sparked further controversy over the vaccine trials, which have been marred by criticism from some quarters.</p><p>The researchers' work on African newborns had previously gained support from prominent figures, including Robert F Kennedy Jr, who has been an outspoken advocate for certain vaccination policies. However, the legitimacy of these policies and the ethics of the research itself remain contentious issues.</p><p>A letter posted online by the Bandim Health Project shows that Guinea-Bissau's national ethics committee at the ministry of public health had given its approval for the trial on 14 July, with a Danish research ethics committee also having approved the study earlier this month.</p><p>Guinea-Bissau's health minister has denied reports that a controversial vaccine trial will proceed despite earlier approvals from national and international ethics committees.</p><p>Quinhin Nantote dismissed the claims as "not even remotely true, stating his position in Portuguese on Thursday. This statement contradicts previous assertions that the study had been given the green light to move forward.</p><p>The proposed trial has sparked widespread concern among health experts due to its design, which would withhold hepatitis B vaccines from 7,000 newborns in the first six weeks of life. In a country where one in five adults are infected with the virus, this approach is deemed particularly reckless.</p><p>According to Tarik Jašarević, spokesperson for the World Health Organization (WHO), any study that denies essential vaccinations to participants is unethical and exposes newborns to serious harm. He emphasized the importance of hepatitis B vaccination at birth as a critical public health intervention.</p><p>The WHO has been closely monitoring the situation through its country office in Guinea-Bissau. Its representatives have been advising the ministry of health on introducing the hepatitis B vaccine, highlighting the potential consequences of this trial for newborns and the broader population.</p><p>The Bandim Health Project, which is co-led by epidemiologist Christine Stabell Benn, has been involved in various research initiatives in the country since its founding by anthropologist Peter Aaby in 1978.</p><p>The Bandim Health Project has been involved in various research initiatives in Guinea-Bissau since its founding by anthropologist Peter Aaby in 1978. This has included a study on the diphtheria-tetanus-pertussis (DTP) vaccine, which was conducted multiple times with differing results.</p><p>Kennedy's praise for the researchers, who he has referred to as the deities of vaccine research", is notable given the controversy surrounding their work. Specifically, his endorsement of Aaby's research led him to halt US funding to Gavi, the Vaccine Alliance, citing concerns about vaccine safety and efficacy.</p><p>Christine Stabell Benn, a key figure in the Bandim Health Project, has been involved in efforts to inform vaccination policy at home and abroad. As a member of the ACIP hepatitis B working group, she presented evidence to US regulators on the universal birth recommendation for hepatitis B vaccines.</p><p>Stabell Benn's work with the ACIP is also notable given her partnership with Tracy Beth Høeg, a former top official with the FDA who has expressed concerns about unnecessary vaccines. Together, they hosted a podcast that explored issues related to vaccine development and implementation.</p><p>The Bandim organization's impact on Guinea-Bissau's health and research capacities remains unclear despite its long presence in the country. A report from Stand Up for Science suggests that the organization may have done little to improve public health outcomes over the past five decades, raising questions about its effectiveness as a research partner.</p><p>Guinea-Bissau's fragile state has been highlighted by a recent police raid on RFK Jr's research organization in the country. The nation is still reeling from a military coup that took place less than a year ago, making it challenging for clinical trials to be conducted safely and effectively.</p><p>The lack of public health infrastructure in Guinea-Bissau means that Bandim often serves as the only option for desperate individuals seeking medical care. However, this has also led to significant distrust among citizens towards the organization, according to Colette Delawalla, an American health researcher and founder of Stand Up for Science.</p><p>The police raid on RFK Jr's research facility underscores Guinea-Bissau's precarious situation as it tries to protect its youth from exploitation by powerful Western nations.</p><p><em>The Guardian World</em>: <a href="https://www.theguardian.com/world/2026/oct/20/rfk-jr-vaccine-researchers-offices-raided-guinea-bissau">https://www.theguardian.com/world/2026/oct/20/rfk-jr-vaccine-researchers-offices-raided-guinea-bissau</a></p>]]></content:encoded>
      <enclosure url="https://noti.group/media/rfk-jr-s-deities-of-vaccine-research-raided-by-police-in-guinea-bissau.webp" type="image/webp" length="0"/>
      <media:content url="https://noti.group/media/rfk-jr-s-deities-of-vaccine-research-raided-by-police-in-guinea-bissau.webp" medium="image" width="1200" height="630"><media:title>Vaccine Trial Researchers&apos; Offices Raided by Police in Guinea-Bissau</media:title></media:content>
    </item>
    <item>
      <title>US Food and Drug Administration Considers Easing Access to Unproven Peptide Drugs</title>
      <link>https://noti.group/us-food-and-drug-administration-considers-easing-access-to-unproven/</link>
      <guid isPermaLink="true">https://noti.group/us-food-and-drug-administration-considers-easing-access-to-unproven/</guid>
      <pubDate>Fri, 16 Oct 2026 17:05:59 GMT</pubDate>
      <dc:creator>Noti Group</dc:creator>
      <category>Technology</category>
      <description><![CDATA[The US Food and Drug Administration is considering easing access to unproven peptide drugs despite concerns over their safety and efficacy.]]></description>
      <content:encoded><![CDATA[<p>The US Food and Drug Administration (FDA) is considering easing access to unproven peptide drugs despite concerns over their safety and efficacy. This move has been proposed by Health Secretary Robert F. Kennedy Jr., who has been promoting these substances through his Make America Healthy Again movement.</p><p>According to a filing notice on an Office of Management and Budget website, the FDA has submitted an "Interim Access Policy for review by the White House. While details about the policy are scarce, individuals familiar with the proposal have revealed that it would grant the agency enforcement discretion over certain peptide drugs. This means the FDA could choose not to enforce current restrictions on these substances and provide reassurance to specialty pharmacies looking to produce them.</p><p>Enabling the sale of unproven peptides has raised concerns among FDA staff scientists, who have pointed out that these substances lack sufficient research to establish their safety and efficacy. Moreover, there is a risk they may cause harm to those using them. The proposal's focus on easing access to peptide drugs contradicts this scientific scrutiny.</p><p>A request for comment from the Department of Health and Human Services, which oversees the FDA, has gone unanswered so far.</p><p>The proposal by Robert F. Kennedy Jr., a prominent advocate for health freedom, to have the US Food and Drug Administration (FDA) reconsider its stance on unproven injectable peptide drugs has sparked controversy.</p><p>These peptides, which are currently being re-reviewed by the FDA, were initially deemed to lack sufficient data on safety and efficacy, posing potential risks to users. Despite this, they remain popular among certain groups, including those in the MAHA community who claim that they can improve appearance, boost energy, and aid in injury recovery.</p><p>The peptides' popularity has led some sellers to make unsubstantiated claims about their benefits, with Kennedy himself being a self-proclaimed big fan of these products. In fact, he has vowed to end what he calls the FDA's war on peptides" since taking office.</p><p>As part of this effort, the FDA announced in April that it would reconsider 12 unproven peptides, and in June, Kennedy appointed new members to a key advisory panel tasked with reviewing them. However, at least six of these appointees have ties to businesses or clinics related to peptides, raising concerns about potential conflicts of interest.</p><p>In a July meeting, the panel voted to recommend adding six out of the first seven peptides considered back to the list of drugs that compounding pharmacies can make, despite objections from FDA staff scientists who maintain that these products still lack crucial safety and efficacy data.</p><p>A recent report suggests that the FDA may adopt a new approach to regulating compounding pharmacies, which could potentially ease access to unproven peptides. This move would bypass the formal rulemaking process, which is typically time-consuming and involves multiple rounds of public comment.</p><p>The Center for Science in the Public Interest (CSPI) has expressed strong opposition to this proposal, arguing that it puts consumers at risk of serious injury from unsupported claims about the benefits of these peptides. In a letter to Acting FDA Commissioner Kyle Diamantas, CSPI president Pete Lurie urged him to disregard the panel's recommendations.</p><p>If adopted, the new enforcement discretion could provide access to unproven peptides during the ongoing rulemaking process or as an alternative to it.</p><p><em>Ars Technica</em>: <a href="https://arstechnica.com/health/2026/10/rfk-jr-proposes-fda-look-the-other-way-on-unproven-peptides-report-says/">https://arstechnica.com/health/2026/10/rfk-jr-proposes-fda-look-the-other-way-on-unproven-peptides-report-says/</a></p>]]></content:encoded>
      <enclosure url="https://noti.group/media/rfk-jr-proposes-fda-look-the-other-way-on-unproven-peptides-report-say.webp" type="image/webp" length="0"/>
      <media:content url="https://noti.group/media/rfk-jr-proposes-fda-look-the-other-way-on-unproven-peptides-report-say.webp" medium="image" width="1400" height="788"><media:title>US Food and Drug Administration Considers Easing Access to Unproven Peptide Drugs</media:title></media:content>
    </item>
    <item>
      <title>Nutrition Expert Says Healthy Eating Is Simpler Than People Think</title>
      <link>https://noti.group/nutrition-expert-says-healthy-eating-is-simpler-than-people-think/</link>
      <guid isPermaLink="true">https://noti.group/nutrition-expert-says-healthy-eating-is-simpler-than-people-think/</guid>
      <pubDate>Wed, 14 Oct 2026 16:00:06 GMT</pubDate>
      <dc:creator>Noti Group</dc:creator>
      <category>Lifestyle</category>
      <description><![CDATA[A leading expert in nutrition studies at Stanford University says that good research on healthy eating is often overshadowed by conflicting information.]]></description>
      <content:encoded><![CDATA[<p>Eating well is often seen as a daunting task, but according to Christopher Gardner, a leading expert in nutrition studies at Stanford University, it's actually more straightforward than people think. Gardner, who has spent over 30 years researching nutrition and advising official bodies on the latest science, believes that a lot of good research is out there, but it's often overshadowed by conflicting information.</p><p>The problem, says Gardner, is that we've overcomplicated the question of what to eat. In an era where social media and wellness trends dominate, people are bombarded with conflicting advice on healthy eating. This has led to a lot of confusion, making it difficult for individuals to make informed choices about their diets.</p><p>Gardner's expertise in nutrition was recently recognized by the US government when he was invited to serve on the dietary guidelines advisory committee. As part of this role, Gardner and his colleagues spent two years reviewing the official guidelines for healthy eating and recommending updates. Their 400-page report was a culmination of extensive research and analysis.</p><p>However, despite their efforts, the committee's report was summarily dismissed by Robert F Kennedy Jr, who had recently taken over as health secretary in the Trump administration. Gardner describes this experience as "a tonne of work that was ultimately met with rejection.</p><p>Gardner believes that expert advice is more necessary than ever, given the noise and misinformation surrounding nutrition. His new book, Food Sense, aims to provide straightforward, science-backed guidance on what to eat and why. By distilling complex research into accessible language, Gardner hopes to empower individuals to make better choices at every meal.</p><p>When asked about his motivation for writing the book, Gardner explained that he wanted to create a resource that would help people navigate the complexities of healthy eating without feeling overwhelmed or judged. He notes that many people approach nutrition with a sense of guilt or anxiety, but ultimately want to do their best with what they have available.</p><p>Gardner's approach is refreshingly optimistic, emphasizing the importance of making progress rather than achieving perfection. By focusing on small, achievable goals, individuals can develop healthier eating habits without feeling overwhelmed by conflicting advice or unrealistic expectations.</p><p>In an effort to cut through the noise and misinformation surrounding nutrition, Gardner aims to provide a clear and practical guide for making informed choices about diet. With his extensive experience in research and advising, he is well-positioned to offer expert guidance that is grounded in science and accessible to everyone.</p><p>The debate over healthy eating is often fueled by conflicting information from various sources.</p><p>Different scientific approaches and methodologies contribute to the complexity of nutritional research. In one study, researchers investigated whether consuming real garlic or garlic supplements can lower levels of bad LDL cholesterol in the blood. The aim was not to definitively answer whether garlic is beneficial for overall health but rather to examine its effects under specific conditions.</p><p>As a researcher with extensive experience, I have noticed that even when scientists from different fields come together to review studies and provide recommendations, they often find common ground. This suggests that there is more agreement than meets the eye on what constitutes healthy eating.</p><p>Despite this apparent consensus, nutrition advice can seem contradictory due to various factors.</p><p>Headlines often sensationalize findings by proclaiming a single food or nutrient as either beneficial or detrimental. However, in reality, research typically reveals a more nuanced picture. For instance, studies on eggs have shown that initial conclusions were later refined as new evidence emerged, leading to consistent advice over time.</p><p>Consumers are often overwhelmed by the sheer volume of information available, making it difficult for them to navigate the complexities of healthy eating.</p><p>The food industry plays a significant role in this confusion, shifting blame onto consumers and implying that they should be able to make informed choices without guidance. However, given the abundance of conflicting advice, it can be challenging for individuals to know what to do.</p><p>The simplicity of healthy eating often gets lost in the sea of conflicting advice and misinformation. Nutrition experts are unanimous about one thing: a balanced diet rich in whole foods is essential for maintaining good health. However, given the abundance of competing opinions, it can be challenging for individuals to know what to do.</p><p>A well-known phrase coined by author Michael Pollan has been widely quoted but not always heeded: Eat food. Not too much. Mostly plants. While this message may seem straightforward, its impact is often diluted due to the complexity of modern diets. As a scientist, it's essential to rely on evidence-based advice rather than catchy slogans.</p><p>The proliferation of scientific research and technological advancements has led to a surge in interest in personalized nutrition. The idea of tailoring one's diet based on individual gut microbiome profiles is an exciting area of study. However, the reality is that classifying hundreds of gut microbes as healthy or pathogenic is a daunting task. This complexity has created a market for products promising tailored diets.</p><p>While precision medicine holds promise, the commercial industry often prioritizes profits over scientific understanding. The concept of gut shots, supplements designed to support gut health, is an example of this trend. Rather than relying on these products, individuals would be better off focusing on established nutritional principles: consuming a variety of fruits, vegetables, and legumes.</p><p>Ultra-processed foods have become the latest target in the ongoing debate over healthy eating. In the US, 60% of the average diet consists of such foods. The term ultra-processed was coined by Brazilian scientist Carlos Monteiro to describe products containing added sugars, salt, refined grains, and saturated fats, as well as cosmetic additives.</p><p>However, critics argue that the phrasing is misleading, implying a level of processing that may not be entirely accurate. Consider the example of oats: from groats to steel-cut oats, to rolled oats, and oat flour, each one represents a different level of processing, yet they are all still essentially just oats. Dr Monteiro's focus on cosmetic additives is a crucial aspect of understanding ultra-processed foods.</p><p>The proliferation of processed foods has led to the widespread availability of products containing artificial flavors, colors, emulsifiers, gelling agents, and foaming agents. These additives may be seen as mere embellishments but can have significant impacts on human health. As with any industry, it's essential to separate marketing hype from actual nutritional value.</p><p>In evaluating the role of ultra-processed foods in our diets, it's crucial to consider the bigger picture: how do these products fit into a broader pattern of consumption? By examining the complex relationships between food production, processing, and consumer choices, we can gain a deeper understanding of the challenges facing individuals seeking healthy eating advice.</p><p>The term ultra-processed is often misused to describe foods that have been altered by additives, but health professionals are more concerned about products like cookies'n'cream high protein cereals, which are inherently unhealthy.</p><p>Nutrition experts argue that there's no such thing as a superfood, and even dark chocolate should be considered an occasional treat rather than a healthy staple. This mindset shift can help individuals make better choices when it comes to their diet.</p><p>One rule that works for making overall healthier choices is to aim to eat well 80% of the time. By allowing room for exceptions, individuals are more likely to stick to a balanced diet and avoid restrictive eating patterns.</p><p>For example, if an average American is accustomed to sugary breakfast cereals, switching to eggs as a better option can be a good start. However, adding cheese, sausage, and bacon to eggs creates a dish high in saturated fats.</p><p>The benefits of coffee consumption are often overlooked, but it was included in the US dietary guidelines in 2015 as a beverage consistent with better health, even at moderate levels of three to five cups per day. This is typically achieved by drinking black coffee or adding minimal amounts of sweetener and dairy.</p><p>Eating habits can be changed when individuals align their food choices with their personal values rather than relying solely on scientific evidence. This approach often coincides with healthier eating patterns.</p><p>When faced with a choice between a steak and a salad, it's easy to put off making the healthy decision until tomorrow. However, understanding the broader impacts of food production can motivate individuals to make more sustainable choices that benefit not only their health but also the environment and those involved in food production.</p><p>Individuals who understand more about the food they consume are more likely to consider the effects of their choices on others, including workers in slaughterhouses, the environment, and animal welfare. This awareness can help drive positive change in eating habits.</p><p>Nutrition experts often focus on biochemical pathways, but there's a broader aspect to consider: the connections between food and various social and environmental issues.</p><p>This awareness can lead to easier behavior change and maintenance, as individuals are more likely to stick to their choices when they understand the reasons behind them.</p><p>A 2023 study comparing vegan and omnivore diets in identical twins showed significant benefits for the vegan group. However, this doesn't necessarily mean that everyone should adopt a vegan diet.</p><p>Some critics argue that the term vegan can be polarizing, implying a strict adherence to plant-based eating. To avoid this connotation, experts now often use the term plant-based, even when referring to packaged foods.</p><p>This shift in terminology is part of a broader trend towards promoting whole-food, plant-rich diets. Such an approach emphasizes flavor and variety while allowing for flexibility in food choices.</p><p>The concept of the protein flip suggests reorienting the plate with vegetables, grains, and beans as the central components, then adding small amounts of meat if desired. This approach aims to reduce polarization between vegans and carnivores.</p><p>By getting omnivores to eat less meat, a global impact can be achieved more effectively than by doubling the number of vegans. This is because even moderate reductions in meat consumption can lead to significant environmental benefits.</p><p>A nutrition expert was part of a 2025 dietary guidelines advisory committee that produced a comprehensive report after two years of work. The panel's recommendations were ultimately dismissed, causing disappointment and frustration among its members.</p><p>The dismissal of the committee's report was particularly disheartening given the amount of time and effort invested by its members, who had contributed over 1,000 hours each to the project.</p><p>The controversy surrounding the dismissed committee's report has been a subject of debate among health experts and advocates. The government's claims of conflicts of interest against the original committee have been met with skepticism, as many of these connections were publicly disclosed decades ago and posed little to no threat to the integrity of their work.</p><p>A stark contrast was observed in the new committee tasked with replacing the dismissed one. An analysis revealed that five out of nine advisers had direct ties to the meat and dairy industries, raising concerns about potential biases and conflicts of interest. This revelation has sparked criticism regarding the hypocrisy displayed by those responsible for dismissing the original report.</p><p>The dismissal of the report was also criticized due to its use of a health equity" lens, which the new committee deemed inappropriate for scientific purposes. However, this framework had been explicitly requested as part of the task, with the aim of creating dietary guidelines that catered to diverse populations, including those from different racial and ethnic backgrounds.</p><p>The controversy surrounding the dismissed report has left many questioning the motives behind its dismissal and the potential impact on public health policies.</p><p><em>The Guardian Life and Style</em>: <a href="https://www.theguardian.com/wellness/2026/oct/14/christopher-gardner-food-sense-interview">https://www.theguardian.com/wellness/2026/oct/14/christopher-gardner-food-sense-interview</a></p>]]></content:encoded>
      <enclosure url="https://noti.group/media/try-to-eat-really-well-80-of-the-time-nutrition-expert-says-healthy-ea.webp" type="image/webp" length="0"/>
      <media:content url="https://noti.group/media/try-to-eat-really-well-80-of-the-time-nutrition-expert-says-healthy-ea.webp" medium="image" width="1200" height="630"><media:title>Nutrition Expert Says Healthy Eating Is Simpler Than People Think</media:title></media:content>
    </item>
    <item>
      <title>Vaccine Trial Involving Newborns Given Green Light to Proceed</title>
      <link>https://noti.group/vaccine-trial-involving-newborns-given-green-light-to-proceed/</link>
      <guid isPermaLink="true">https://noti.group/vaccine-trial-involving-newborns-given-green-light-to-proceed/</guid>
      <pubDate>Fri, 09 Oct 2026 21:36:18 GMT</pubDate>
      <dc:creator>Noti Group</dc:creator>
      <category>World News</category>
      <description><![CDATA[A research study involving withholding hepatitis B vaccines from thousands of newborns in Guinea-Bissau has been approved to proceed.]]></description>
      <content:encoded><![CDATA[<p>A highly contentious research study that involves withholding hepatitis B vaccines from thousands of newborns in Guinea-Bissau has been given the green light to proceed this week. The trial is a key component of a broader vaccine strategy championed by Robert F Kennedy Jr, who has long been an outspoken critic of vaccination policies.</p><p>Kennedy's views on vaccines have been shaped by his role as secretary of the US Department of Health and Human Services (HHS) under the Trump administration. This administration has been notable for its efforts to reduce vaccine recommendations and cast doubt on their safety and effectiveness. Kennedy has publicly praised researchers involved in a similar trial, which was presented at an anti-vaccine conference last month.</p><p>According to Paul Offit, an infectious disease physician at Children's Hospital of Philadelphia, Kennedy's ultimate goal is to eliminate the birth dose of hepatitis B vaccine in the US. He wants to make it so we don't use a birth dose here in this country, Offit said. This would require taking advantage of countries with more lenient regulations and ethics standards.</p><p>The trial itself will involve enrolling 14,000 infants in Guinea-Bissau, with half receiving the hepatitis B vaccine at birth and the other half going without it for the first six weeks of life. Critics have raised concerns about the ethics of conducting such a trial in a developing country, where children may be more vulnerable to the risks associated with delayed vaccination.</p><p>The Danish researchers behind the study are set to begin enrolling participants in Guinea-Bissau, despite ongoing controversy surrounding their research. The implications of this trial and its potential impact on global vaccine policies remain unclear, but it is likely to continue sparking intense debate in the coming weeks.</p><p>The ethics committee at the University of Southern Denmark has given its approval for a controversial vaccine trial to proceed, following a similar decision from officials in Guinea-Bissau. This development comes after international outcry earlier this year led health minister Quinhin Nantote to initially suspend the project.</p><p>Stig Børsen Hansen, a founding member and reviewer of the study, has resigned from the group in protest over major ethical concerns. He cited the trial's design, which involves enrolling newborns in a lottery to test a hypothesis, effectively putting them at risk of contracting hepatitis B. This could cause irreversible lifelong damage.</p><p>Hansen expressed his objections, stating that children who "lost the lottery would be exposed to the risk of hepatitis B as part of a research project. He argued that their infection would occur by design, highlighting the potential ethical implications of the trial's setup.</p><p>Three other members of the committee have also resigned in protest against the trial. The controversy surrounding this vaccine trial is likely to continue, with various stakeholders weighing in on its merits and drawbacks.</p><p>The US Centers for Disease Control and Prevention has allocated $1.6m from its budget for the project, which will be matched by private funding from organizations including the Pershing Square Foundation and the Bluebell Foundation.</p><p>The trial's updated protocol has been disclosed, revealing significant changes to the study design.</p><p>In response to concerns raised about the potential for hepatitis B transmission through casual contact, researchers will now test mothers for the virus before administering the vaccine to their newborns.</p><p>This new approach ensures that babies born to mothers who test positive for hepatitis B are not included in the trial, but those born to mothers with negative results may still be enrolled.</p><p>The updated protocol has not been made publicly available, leaving many questions unanswered about the trial's methodology and ethics.</p><p>Experts have long emphasized the risks associated with hepatitis B transmission, which can occur through community exposures or even everyday activities such as sharing personal care items.</p><p>The controversial vaccine trial has received approval from a Danish research ethics committee, despite concerns raised by some members about its safety and efficacy.</p><p>The University of Southern Denmark's committee had previously not considered medical studies, but made an exception to review this particular case. Committee members with expertise in the field argued against approving the trial, but the majority voted in favor of moving forward.</p><p>Støvring, a member of the committee, expressed surprise at the decision, stating that it was unusual for such a case to be brought before them. The national ethics committee in Denmark typically oversees medical research, but this study fell outside their jurisdiction since it would take place abroad.</p><p>The conditions in Guinea-Bissau make it an attractive location for the trial. The country has one of the highest rates of hepatitis B infection worldwide, with approximately 18% of adults carrying the virus. This high prevalence rate presents a unique opportunity to test the vaccine's effectiveness in a real-world setting.</p><p>The Bandim Health Project, a research initiative led by Danish scientists Peter Aaby and Christine Stabell Benn, has been operating in Guinea-Bissau for several decades. This long-standing presence within the country's health system has raised concerns about potential conflicts of interest.</p><p>Kennedy Jr., a vocal critic of vaccination policies, has expressed admiration for the work of the Bandim researchers, describing them as the deities of vaccine research." He cited one of their studies to support his claim that vaccines can cause mass injuries and catastrophic effects, which are allegedly being concealed. However, another study conducted by the same team found no adverse outcomes.</p><p>The upcoming trial will focus on the impact of vaccination on mortality rates, as well as its potential effects on skin conditions and neurodevelopmental disorders. Critics argue that this research is misguided, given the established benefits of immunization against serious diseases such as hepatitis B. They point out that the World Health Organization recommends vaccinating newborns against hepatitis B at birth.</p><p>The trial has sparked controversy, with some questioning the ethics of conducting such a study in Guinea-Bissau. The Africa CDC has expressed opposition to the trial, citing concerns about its methodology and potential impact on public health policies. An official from the organization stated that there are ongoing discussions between the US and Guinea-Bissau regarding the trial.</p><p>The planned vaccination campaign against hepatitis B was initially set to begin in 2027 but has been pushed back to 2028. This delay is likely due to the controversy surrounding the Bandim Health Project's research initiative, which has raised concerns about the country's commitment to immunization programs.</p><p>The Bandim Health Project's research initiative has been met with criticism from experts who argue that it poses unnecessary risks to children participating in the trial.</p><p>The controversy surrounding this project suggests a lack of urgency in implementing standard care practices in Guinea-Bissau, allowing researchers to proceed with their vaccine trial without addressing underlying concerns.</p><p><em>The Guardian World</em>: <a href="https://www.theguardian.com/society/2026/oct/09/vaccine-trial-guinea-bissau-rfk-jr">https://www.theguardian.com/society/2026/oct/09/vaccine-trial-guinea-bissau-rfk-jr</a></p>]]></content:encoded>
      <enclosure url="https://noti.group/media/controversial-vaccine-trial-touted-by-rfk-jr-gets-go-ahead-in-guinea-b.webp" type="image/webp" length="0"/>
      <media:content url="https://noti.group/media/controversial-vaccine-trial-touted-by-rfk-jr-gets-go-ahead-in-guinea-b.webp" medium="image" width="1200" height="630"><media:title>Vaccine Trial Involving Newborns Given Green Light to Proceed</media:title></media:content>
    </item>
  </channel>
</rss>
